Assay Method Information |
|
| Bromodomain Binding Assay |
Description: | Bromodomain binding assays were carried out in Reaction Biology (PA, USA) to test the degrees of the inventive compounds in inhibiting the human BRD4 bromodomain 1 by Alpha-screen assay method.Recombinant human BRD4 bromodomain 1 expressed in E. coli with N-terminal His-tag was used as the enzyme target.A synthetic peptide (SGRGACKGGACKGLGACKGGAACKRH-GSGSK-biotin) containing 1 to 21th amino acids of histone H4 acetylated at lysine 5, 8, 12 and 16 and conjugated to biotin was purchased from Millipore.BRD4-1 (44 to 170th amino acids; Genbank Accession # NM_058243) was expressed in E. coli with N-terminal His-tag (see, Ni-NTA spin Kit Handbook (Qiagen), second edition, January, 2008). Nickel-Chelate ALPHA acceptor beads (Perkin Elmer) were used to specifically bind BRD4-1, and ALPHA streptavidin donor beads (Perkin Elmer) were used because they specifically recognized the biotinylated H4 peptide. Binding of BRD4-1 to the synthetic peptide resulted in proximity of the donor and acceptor beads, which leads to an increase in ALPHA signal whereas in a decrease in ALPHA signal.BRD binding assays were performed in a mixture comprising 50 mM Hepes (pH7.5), 100 mM NaCl, 0.05% CHAPS, 0.1% BSA, and 1% DMSO. After an assay reaction time of 60 min at 25° C., binding was measured with streptavidin donor beads and nickel-chelate acceptor beads. ALPHA signal was detected on Enspire (Ex/Em=680/520-620 nm). IC50 values were calculated from the fit of the dose-response curves. All IC50 values represent geometric mean values of a minimum of four determinations. These assays generally produced results within 3-fold of the reported mean. |
Affinity data for this assay | |
---|---|
If you find an error in this entry please send us an E-mail |
Home |
| |
Search |
| |
Deposit |
| |
SiteMap |
| |
About us |
| |
Email us |
| |
Info |
|
©2000 BindingDB. All rights reserved. |